Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis
No information was yet available over the effect of levocetirizine in children under 12 years. The aim of this double-blind, placebo-controlled study was to assess the efficacy and safety of levocetirizine in children from 6 to 12 years old with perennial allergic rhinitis due to house dust mites.
Rhinitis, Allergic, Seasonal
Drug: levocetirizine dihydrochloride
|Study Design:||Allocation: Randomized
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
|Official Title:||Trial to Compare the Efficacy and Safety of Levocetirizine 5 mg od and Fexofenadine 120 mg od in Reducing Symptoms of Seasonal Allergic Rhinitis in Grass Pollen Sensitized Adults|
- Change from baseline of the mean Major symptom complex score over the last 2 hours of a 24-hour coverage
- The change from baseline of the mean MSC score over time interval 3
- the change from baseline of the mean MSC score over time intervals 1 and 4.
|Study Start Date:||September 2002|
|Study Completion Date:||December 2002|
|Primary Completion Date:||December 2002 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00542607
|Study Director:||UCb Clinical Trial Call Center||UCB Pharma|